ISM offers individually tailored, flexible treatment and support until sobriety becomes irreversible and relapse is untenable. Created and developed by Dr. Kaminski at The Institute of Integrative Psychiatry, the Irreversible Sobriety Method addresses a fundamental gap in conventional addiction treatment: the disconnect between achieving sobriety in a controlled clinical setting and sustaining it amid the pressures and complexities of everyday life.
Dr. Kaminski’s ISM is built on a foundational principle: It is easier becoming sober than remaining sober. At the core of Dr. Kaminski’s approach is the conviction that the successful journey to irreversible sobriety must entail working with the person inside their everyday life, helping them remain sober where it matters most; at home, at work, and within their relationships and communities.
Remaining sober calls for comprehensive, sustained support in relapse prevention until sobriety becomes a way of life rather than a daily struggle. ISM recognizes that recovery is not a single event but an ongoing process, one that demands clinical expertise, personal commitment, and a treatment framework that evolves alongside the person.
ISM is designed to help each person in recovery achieve three interconnected goals:
The first two goals are commonly addressed, with varying degrees of success, by conventional rehabilitation services. But the third goal – helping a person move on with their life – cannot be adequately addressed within the walls of a rehab facility, no matter how well-resourced or accommodating it may be. A rehab center, by definition, is not real life. Typically, a person in rehab takes time away from their everyday pressures and dedicates themselves entirely to sobriety. This can be an essential first step. However, the moment of greatest vulnerability arrives soon after discharge, when the person re-encounters the stresses, triggers, and routines of their real life – minus the substance.
This is not a theoretical concern. According to the National Institute on Drug Abuse (NIDA), between 40% and 60% of individuals treated for substance use disorders will experience relapse – a rate comparable to relapse rates for other chronic illnesses such as hypertension and asthma. More strikingly, research indicates that up to 85% of individuals experience relapse within the first year following discharge from residential treatment, with the highest-risk period falling within the first 30 to 90 days after leaving a facility. For those struggling with opioid dependence, relapse can occur within days or weeks of detox, carrying the added danger of fatal overdose due to reduced tolerance.
The addiction treatment field has long grappled with what clinicians call the “revolving door” phenomenon: individuals cycle through repeated episodes of detox and short-term residential rehab, achieving temporary sobriety only to relapse upon returning to their everyday environment. Each cycle erodes confidence, strains family relationships, and increases both medical costs and health risks. Research shows that individuals with several previous treatment episodes often experience higher relapse rates than first-time treatment seekers, suggesting that the standard model of episodic, facility-based care may itself become part of the problem when it fails to address life beyond discharge.
A growing body of research supports the core premise underlying ISM: that long-term, individually tailored, life-integrated treatment produces meaningfully better outcomes than time-limited residential care alone.
NIDA’s own treatment principles state that programs lasting 90 days or longer, combined with robust continuing care, offer the best chance for sustained sobriety. A comprehensive review published in Social Science & Medicine examined 20 studies evaluating long-term treatment and support models and found that 12-month programs consistently produced positive outcomes, while shorter interventions yielded more mixed results. Separately, studies on Contracting, Prompting, and Reinforcing (CPR) aftercare models found that patients in structured continuing care were more likely to complete at least three months of aftercare (55% vs. 36%), remained in treatment significantly longer, and were more likely to be abstinent at 12 months (57% vs. 37%).
According to NIDA, individualized treatment plans that account for a person’s specific history, co-occurring conditions, family dynamics, and social environment consistently outperform standardized group-based approaches. The Substance Abuse and Mental Health Services Administration (SAMHSA) and the Recovery Research Institute have both identified personalized treatment – including comprehensive initial assessment and assertive linkages to community resources – as a hallmark of quality addiction care. When people receive treatment that feels “inherently theirs,” engagement and commitment to recovery increase substantially.
Critically, the evidence suggests that treatment delivered within a person’s actual living environment addresses the very triggers and stressors that residential programs cannot replicate. Ongoing participation in therapy, support structures, and sober living arrangements within the community has been shown to reduce relapse rates by as much as 50% compared to individuals who discontinue care after an initial residential stay. A 2022 study in JAMA Psychiatry further demonstrated that patients who maintained access to follow-up treatment, including through telehealth, were 27% more likely to remain engaged in care three months after discharge.
Encouragingly, research demonstrates that once a person maintains 12 months of continuous sobriety, the risk of relapse drops significantly. By five years, the odds of long-term sustained recovery reach approximately 85%, comparable to the general population. This underscores a central ISM conviction: if the right support is in place during the critical early months and years of recovery, lasting sobriety is not only possible but probable.
ISM concentrates on all three recovery goals by offering individually tailored, flexible treatment and support within the fabric of the person’s daily life. Rather than removing someone from their world, ISM brings a multidisciplinary clinical team into it.
Each person’s care is supervised by Dr. Kaminski and supported by a team of specialists drawn from multiple clinical disciplines. All team members are selected and trained by Dr. Kaminski.
Clinical symptoms such as depression, anxiety, body image issues, and eating disorders are identified and treated as integral parts of the recovery process—not as secondary concerns to be addressed later.
The treatment of each person is individually designed and continuously adapted to accommodate their lifestyle, travel commitments, professional obligations, family relationships, and other relevant aspects of their life. ISM does not require a person to put their life on hold. Instead, it integrates clinical support into the rhythms and demands of real life, precisely where lasting recovery must take root.
In the event of a crisis, ISM responds immediately and proportionally. If clinically advisable, intensive treatment is provided at home with around-the-clock supervision, allowing the person to stabilize without the disruption of facility admission. If admission cannot be avoided, the person is placed in premier partner facilities with which we maintain an ongoing collaborative relationship, ensuring continuity of care and a seamless return to the ISM framework upon discharge.
The evidence is clear: episodic, facility-based treatment alone is insufficient for the majority of people struggling with addiction. Real, lasting recovery requires sustained clinical engagement within the context of a person’s actual life – their home, their work, their relationships, and their community. ISM was designed to meet this need. By combining the rigor of evidence-based pioneering psychiatric care with the flexibility and personalization of a bespoke recovery program, ISM offers what conventional rehab cannot: a path to sobriety that endures because it was built into the life the person actually lives.